Natural Products Insider is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
HomeRegulatoryCargills Canola Lecithin Granted GRAS letter of no objection by US FDA

Cargills Canola Lecithin Granted GRAS letter of no objection by US FDA

The U.S. Food and Drug Administration (FDA) has issued a GRAS (Generally Recognized As Safe) Letter of No Objection for Cargill’s canola lecithin for use as a multipurpose ingredient in a variety of foods.
TAGS: Ingredients
Hide comments
account-default-image
user not logged in

More information about text formats

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish
Related
FDA buildings 2020
FDA releases guidance in effort to boost NDI submissions
May 20, 2022
MLM for web.jpg
Proposed FTC rules target multilevel marketers, ‘dead-end debt traps’
May 19, 2022
Various dietary supplements 2019
User-fee draft in Senate calls for dietary supplement product listing
May 17, 2022
NAC supplement
Consumers tout NAC in comments about recent FDA guidance
May 17, 2022